| Literature DB >> 29707175 |
Vladimir A Shvartz1, Anton R Kiselev1,2,3, Anatoly S Karavaev3,4, Kristina A Vulf1, Ekaterina I Borovkova3, Mikhail D Prokhorov4, Andrey D Petrosyan1, Olga L Bockeria1.
Abstract
Introduction: Our aim was to perform a comparative study of short-term cardiovascular autonomic control in cardiac surgery patients who underwent coronary artery bypass grafting (CABG) or surgical correction of valvular heart disease (SCVHD ).Entities:
Keywords: Cardiovascular Autonomic Control; Coronary Artery Bypass Grafting; Heart Rate Variability; Slow Oscillations; Valvular Heart Disease
Year: 2018 PMID: 29707175 PMCID: PMC5913690 DOI: 10.15171/jcvtr.2018.05
Source DB: PubMed Journal: J Cardiovasc Thorac Res ISSN: 2008-5117
Baseline clinical characteristics of patients in the studied groups
|
|
|
|
|
|
| Age, y | Me (LQ, UQ) | 63 (57, 67) | 58 (47, 65) | 0.086 |
| Male sex | No. (%) | 30 (71.4%) | 20 (55.6%) | 0.152 |
| BMI, kg/m2 | Me (LQ, UQ) | 29.2 (27.3, 32.9) | 25.6 (23.2, 29.0) | 0.001 |
| Prior MI | No. (%) | 30 (71.4%) | 0 (0) | <0.001 |
| Prior stroke | No. (%) | 2 (4.8%) | 2 (5.6%) | 0.874 |
| Hypertension | No. (%) | 40 (95.2%) | 18 (50.0%) | <0.001 |
| Smoking | No. (%) | 15 (35.7%) | 6 (16.7%) | 0.063 |
| Diabetes | No. (%) | 7 (16.7%) | 0 (0) | 0.012 |
| COPD | No. (%) | 3 (7.1%) | 0 (0) | 0.107 |
| Prior PCI | No. (%) | 8 (19.0%) | 0 (0) | 0.007 |
| Baseline SBP, mm Hg | Me (LQ, UQ) | 130 (120, 130) | 120 (110, 130) | 0.029 |
| Baseline DBP, mm Hg | Me (LQ, UQ) | 80 (70, 85) | 78 (70, 80) | 0.014 |
| Baseline LVEF, % | Me (LQ, UQ) | 60 (55, 62) | 66 (60, 67) | 0.001 |
| LVEF in 5-7 days after surgery, % | Me (LQ, UQ) | 59 (54, 64) | 64 (60, 66) | 0.002 |
|
| ||||
| Creatinine, mg/dL | Me (LQ, UQ) | 84 (74, 105) | 69 (61, 88) | 0.044 |
| Glucose, mmol/L | Me (LQ, UQ) | 5.4 (4.9, 6.2) | 5.0 (4.7, 5.2) | 0.051 |
| Leukocytes, *109/mL | Me (LQ, UQ) | 7.4 (6.0, 8.8) | 6.9 (5.4, 7.2) | 0.315 |
| Lactate, mmol/L | Me (LQ, UQ) | 0.9 (0.8, 1.3) | 0.8 (0.7, 1.3) | 0.813 |
| Hematocrit, % | Me (LQ, UQ) | 41 (38, 44) | 40 (37, 42) | 0.779 |
|
| ||||
| ACE inhibitors | No. (%) | 34 (81.0%) | 10 (27.8%) | <0.001 |
| Beta-blockers | No. (%) | 34 (81.0%) | 8 (22.2%) | <0.001 |
| Statins | No. (%) | 30 (71.4%) | 8 (22.2%) | <0.001 |
| Diuretics | No. (%) | 15 (35.7%) | 16 (44.4%) | 0.436 |
| Calcium antagonists | No. (%) | 10 (23.8%) | 2 (5.6%) | 0.029 |
|
| ||||
| ACE inhibitors | No. (%) | 36 (85.7%) | 15 (41.7%) | <0.001 |
| Beta-blockers | No. (%) | 38 (90.5%) | 10 (27.8%) | <0.001 |
| Statins | No. (%) | 40 (95.2%)* | 8 (22.2%) | <0.001 |
| Diuretics | No. (%) | 16 (38.1%) | 12 (33.3%) | 0.661 |
| Calcium antagonists | No. (%) | 12 (28.6%) | 2 (5.6%) | 0.010 |
|
| ||||
| Cardioplegia | No. (%) | 0 (0 %) | 36 (100%) | <0.001 |
| CPB time, minutes | Me (LQ, UQ) | 73 (56, 98) | 124 (102, 145) | <0.001 |
| ACCT, minutes | Me (LQ, UQ) | ― | 65 (57, 75) | ― |
| PMVT, hours | Me (LQ, UQ) | 13.5 (9.0, 21.5) | 20.0 (13.0, 25.0) | 0.099 |
| Length of ICU stay, days | Me (LQ, UQ) | 1.0 (1.0, 1.0) | 1.0 (1.0, 1.0) | 0.606 |
| Length of hospital stay, days | Me (LQ, UQ) | 7.5 (7.0, 8.0) | 8.0 (7.0, 11.0) | 0.085 |
| Any in-hospital complication | No. (%) | 7 (16.7%) | 14 (38.9%) | 0.039 |
Continuous variables are presented as medians with inter-quartile ranges – Me (LQ, UQ). Categorical data are presented as frequencies and percentages – No. (%). * Significant differences (P < 0.05) from level of similar parameter before surgery.
CABG, coronary artery bypass grafting; SCVHD, surgical correction of valvular heart disease; BMI, body mass index; MI, myocardial infarction; COPD, chronic obstructive pulmonary disease; PCI, percutaneous coronary intervention; SBP, systolic blood pressure; DBP, diastolic blood pressure; LVEF, left ventricular ejection fraction; ACE, angiotensin-converting enzyme; CPB, cardiopulmonary bypass; ACCT, aortic cross clamping time; PMVT, postoperative mechanical ventilation time; ICU, intensive care unit.
Figure 1Cardiovascular autonomic indices before and in 5-7 days after the cardiac surgery
|
|
|
|
|
|
| |||
| Index S, % | 24.7 (18.3, 35.2) | 22.5 (13.4, 27.4) | 0.400 |
| HR, bmp | 67 (60, 72) | 69 (65, 80) | 0.013 |
| SDNN, ms | 34.9 (24.9, 52.3) | 37.7 (28.4, 53.1) | 0.903 |
| TP, ms2 | 493 (311, 1247) | 425 (246, 969) | 0.696 |
| LF, ms2 | 134 (47, 315) | 135 (83, 248) | 0.570 |
| HF, ms2 | 123 (25, 508) | 74 (33, 188) | 0.428 |
| LF% | 24.4 (16.5, 34.6) | 29.4 (17.1, 36.9) | 0.653 |
| HF% | 21.6 (9.5, 47.0) | 20.2 (11.1, 29.7) | 0.422 |
| LF/HF | 1.2 (0.6, 2.7) | 1.4 (0.6, 2.9) | 0.546 |
|
| |||
| Index S, % | 20.3 (10.2, 27.5) | 20.2 (15.5, 28.1) | 0.529 |
| HR, bmp | 78 (73, 87)* | 74 (66, 90) | 0.439 |
| SDNN, ms | 15.6 (11.3, 41.0) | 18.0 (11.1, 71.9) | 0.479 |
| TP, ms2 | 84 (26, 496)* | 125 (36, 2735) | 0.326 |
| LF, ms2 | 27 (7, 150) | 53 (9, 637) | 0.446 |
| HF, ms2 | 11 (5, 201) | 24 (4, 893) | 0.663 |
| LF% | 26.6 (18.1, 36.4) | 30.8 (21.8, 39.8) | 0.526 |
| HF% | 26.3 (10.8, 46.4) | 23.7 (9.7, 43.4) | 0.637 |
| LF/HF | 0.8 (0.5, 3.4) | 1.2 (0.6, 2.9) | 0.586 |
|
| |||
| ΔS, % | -3.1 (-19.0, +5.8) | +0.5 (-14.2, +6.3) | 0.488 |
| ΔHR, bpm | +13 (+1, +28) | +3 (-6, +15) | 0.144 |
| ΔSDNN, ms | -16.0 (-38.9, +17.6) | -14.9 (-26.1, +6.3) | 0.637 |
| ΔTP, ms2 | -293 (-841, -44) | -194 (-640, +234) | 0.304 |
| ΔLF% | +3.4 (-12.6, +12.3) | +1.6 (-12.4, +14.9) | 0.977 |
| ΔHF% | -0.5 (-13.8, +9.2) | +1.7 (-16.8, +24.0) | 0.783 |
| ΔLF/HF | +0.2 (-1.6, +1.1) | 0 (-1.1, +2.5) | 0.532 |
Data are presented as medians with inter-quartile ranges – Me (LQ, UQ). Index S is relative time (in percents) of synchronization between low-frequency oscillations in HRV and PPGV.
* Significant differences (P < 0.05) from level of similar parameter before surgery.
CABG, coronary artery bypass grafting; SCVHD, surgical correction of valvular heart disease; HR, heart rate; SDNN, standard deviations of normal to normal intervals; TP, total power (0 to 0.5 Hz) of HRV spectrum; LF, power of low-frequency band (0.04 to 0.15 Hz) of HRV spectrum; HF, power of high-frequency (0.15 to 0.40 Hz) band of HRV spectrum; LF%, ratio (in percents) of LF to TP; HF%, ratio (in percents) of HF to TP; LF/HF, ratio of LF to HF; ΔS = Safter surgery ‒ Spreoperative; ΔHR = HRafter surgery ‒ HRpreoperative; ΔSDNN = SDNNafter surgery ‒ SDNNpreoperative; ΔTP = TPafter surgery ‒ TPpreoperative; ΔLF% = LF%after surgery ‒ LF%preoperative; ΔHF% = HF%after surgery ‒ HF%preoperative; ΔLF/HF = LF/HFafter surgery ‒ LF/HFpreoperative.
Clinical characteristics and autonomic indices of patients in the selected clusters
|
|
|
|
|
| Preoperative hematocrit, % | 42 (38, 44) | 39 (36, 41) | 0.038 |
|
| |||
| HR, bpm | 70 (62, 78) | 65 (58, 71) | 0.046 |
| TP, ms2 | 768 (311, 2385) | 356 (270, 738) | 0.048 |
| HF, ms2 | 274 (125, 1127) | 34 (21, 73) | <0.001 |
| LF% | 20.4 (14.7, 35.7) | 32.3 (21.1, 36.6) | 0.047 |
| HF% | 40.1 (27.3, 59.4) | 10.1 (5.4, 15.6) | <0.001 |
| LF/HF | 0.6 (0.3, 1.0) | 2.9 (1.9, 4.5) | <0.001 |
|
| |||
| ΔHR, bpm | -1 (-10, +15) | +13 (+4, +24) | 0.018 |
| ΔLF% | +7.6 (0, +12.5) | -1.1 (-13.5, +6.9) | 0.049 |
| ΔHF% | -14.0 (-24.5, -3.1) | +16.5 (+2.0, +34.1) | <0.001 |
| ΔLF/HF | +0.5 (+0.2, +2.6) | -1.7 (-3.2, -0.4) | <0.001 |
Data are presented as medians with inter-quartile ranges – Me (LQ, UQ). We presented only parameters (clinical, autonomic) with statistically significant (P<0.05) differences between the Clusters.
HR, heart rate; SDNN, standard deviations of normal to normal intervals; TP, total power (0 to 0.5 Hz) of HRV spectrum; HF, power of high-frequency (0.15 to 0.40 Hz) band of HRV spectrum; LF%, ratio (in percents) of LF to TP; HF%, ratio (in percents) of HF to TP; LF/HF, ratio of LF to HF; ΔHR = HRafter surgery ‒ HRpreoperative; ΔLF% = LF%after surgery ‒ LF%preoperative; ΔHF% = HF%after surgery ‒ HF%preoperative; ΔLF/HF = LF/HFafter surgery ‒ LF/HFpreoperative.